Literature DB >> 3701526

Methylprednisolone for chemotherapy-induced emesis: a double-blind randomized trial in children.

P Mehta, S Gross, J Graham-Pole, R Gardner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3701526     DOI： 10.1016/s0022-3476(86)81066-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  5 in total

Review 1.  Ondansetron: a review of its use as an antiemetic in children.

Authors:  C R Culy; N Bhana; G L Plosker
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 2.  Nausea and vomiting associated with cancer chemotherapy: drug management in theory and in practice.

Authors:  E S Antonarakis; R D W Hain
Journal:  Arch Dis Child       Date:  2004-09       Impact factor: 3.791

3.  2016 updated MASCC/ESMO consensus recommendations: Prevention of acute chemotherapy-induced nausea and vomiting in children.

Authors:  L Lee Dupuis; Lillian Sung; Alexander Molassiotis; Andrea D Orsey; Wim Tissing; Marianne van de Wetering
Journal:  Support Care Cancer       Date:  2016-08-26       Impact factor: 3.603

4.  Audit of guidelines for effective control of chemotherapy and radiotherapy induced emesis.

Authors:  A B Foot; C Hayes
Journal:  Arch Dis Child       Date:  1994-11       Impact factor: 3.791

Review 5.  Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood.

Authors:  Robert S Phillips; Amanda J Friend; Faith Gibson; Elizabeth Houghton; Shireen Gopaul; Jean V Craig; Barry Pizer
Journal:  Cochrane Database Syst Rev       Date:  2016-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.